Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 80%–85% of total cases and leading to millions of deaths worldwide. Drug resistance is the primary cause of treatment failure in NSCLC, which urges scientists to develop advanced approaches for NSCLC treatment....
Main Authors: | Mai Thi Le, Huyen-Thu Nguyen, Xuan-Hung Nguyen, Xuan-Hai Do, Binh Thanh Mai, Ha Thi Ngoc Nguyen, Uyen Thi Trang Than, Thanh-Hong Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023092885 |
Similar Items
-
Challenges in microRNAs’ targetome prediction and validation
by: Jesus Eduardo Rojo Arias, et al.
Published: (2019-01-01) -
Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer
by: Xinping Zhu, et al.
Published: (2021-04-01) -
Data Integration Reveals the Potential Biomarkers of Circulating MicroRNAs in Osteoarthritis
by: Thuan Duc Lao, et al.
Published: (2021-02-01) -
Dysregulation of MicroRNAs in cancer
by: Chen Pai-Sheng, et al.
Published: (2012-10-01) -
Identification of common carp (<it>Cyprinus carpio</it>) microRNAs and microRNA-related SNPs
by: Zhu Ya-Ping, et al.
Published: (2012-08-01)